Practice
Featured experience
Bristol Myers Squibb €5 billion notes offering
We advised the underwriters on Bristol Myers Squibb Ireland’s inaugural euro issuance
BETA Technologies $1 billion IPO
The shares are listed on the New York Stock Exchange
Vistra $2 billion secured notes offering
The investment-grade notes are due 2028, 2030 and 2035
American Industrial Partners $1.5 billion acquisition of Global Cellulose Fibers
We are advising American Industrial Partners on the transaction
Wayfair $700 million senior secured notes offering
The high-yield notes are due 2030
Primo Brands $1.5 billion debut secondary offering
The shares are listed on the New York Stock Exchange
CSX $600 million senior notes offering
We advised CSX on the investment-grade debt offering
Meritage Homes $500 million senior notes offering
The investment-grade senior notes are due 2035
Sycamore Partners up to $23.7 billion acquisition of Walgreens Boots Alliance
We are advising Sycamore Partners on the transaction
PPG €900 million notes offering
The investment-grade notes are due 2032
Leidos $1 billion notes offering and tender offer
We advised Leidos in connection with the transactions
Emerson €1 billion and $500 million notes offering
The investment-grade debt consists of three tranches of notes
Life Time $699 million secondary offering
The shares are listed on the New York Stock Exchange
AbbVie $4 billion senior notes offering
The investment-grade notes are due 2028, 2030, 2035 and 2055